Da Vinci 5 Sparks Optimism Around Intuitive Surgical, Inc. (ISRG)

Group 1 - Intuitive Surgical, Inc. (NASDAQ:ISRG) is recognized as one of the top 10 healthcare equipment stocks favored by hedge funds [1] - Freedom Capital raised its price target for Intuitive Surgical from $560 to $610, upgrading its rating from Hold to Buy, indicating an upside potential of over 11% [1][2] - Barclays analyst Matt Miksic increased the price target from $686 to $712 while maintaining an Overweight rating, suggesting a revised upside potential of nearly 42% [3] Group 2 - The rating upgrade by Freedom Capital is attributed to a strong topline forecast for the next two years, with the launch of da Vinci 5 expected to drive system sales and procedure volumes in 2026 [2] - Intuitive Surgical operates in the robotic-assisted surgery market, focusing on products that enable minimally invasive care, with key offerings including the da Vinci Surgical System and the Ion endoluminal system [4]